Phosphatase alkaline increased

Drugs with this side effect

• 1,25(OH)2D3
• 5-ASA: postmarketing
• Cancidas: 2% - 19.3%
• L-Dmp: rare
• LY146032
• NSC 352122
• Octreotide
• Triptorelin: 1.7%
• VACV
• Zyprexa Relprevv
• abiraterone
• acamprosate: rare
• acyclovir
• agomelatine
• amphotericin B: 19.2% - 22.2%
• amsacrine
• anastrozole
• aprepitant
• aripiprazole
• atovaquone: 8%
• axitinib: 1% - 34%
• azithromycin: postmarketing
• baclofen
• bexarotene
• bezafibrate
• bicalutamide
• budesonide
• cabozantinib: 3% - 52%
• capecitabine: 0% - 29%
• carbamazepine: common
• carboplatin: 24%
• carvedilol
• cefaclor
• cefadroxil
• cefditoren
• cefepime
• cefuroxime: postmarketing
• cefuroxime axetil
• celecoxib
• cephalexin
• cevimeline
• cidofovir
• ciprofloxacin
• citalopram: rare, infrequent, uncommon
• clomipramine: common
• crizotinib
• cysteamine
• dabrafenib: 0% - 67%
• degarelix
• deprenyl: rare
• desipramine
• dexmedetomidine: postmarketing
• dexrazoxane: 0%
• docetaxel: 1% - 51%
• dolasetron
• donepezil: frequent
• doxorubicin
• duloxetine: very rare, postmarketing
• eletriptan: rare
• entacapone
• ertapenem: postmarketing, 2.8% - 6.6%
• esomeprazole magnesium
• estradiol
• etoposide
• etoricoxib
• everolimus: 0% - 74%
• ezetimibe
• febuxostat
• felbamate: infrequent
• fenofibrate
• fluconazole
• fluoxetine: rare
• flurazepam
• foscarnet
• fosfomycin: postmarketing
• fosfomycin trometamol
• gabapentin: rare
• gadobenate dimeglumine
• galantamine: rare, infrequent
• gemcitabine: 0% - 55%
• gemfibrozil
• gemifloxacin: 0.3% - 0.4%
• hexamethylmelamine
• hydroxybutyrate
• iloprost: 6%
• imatinib: 0% - 5.5%
• irinotecan
• itraconazole: 1% - 3%
• lanreotide
• lansoprazole: postmarketing
• lorazepam: infrequent
• lovastatin
• medroxyprogesterone acetate
• memantine: frequent
• methylphenidate: postmarketing
• minoxidil
• misoprostol: postmarketing
• mycophenolate mofetil: 1.8% - 4.2%
• mycophenolic acid
• nilotinib: 0% - 1%
• nilutamide: 3%
• nimodipine
• norfloxacin: 1.1%
• ofloxacin
• olanzapine: very rare, postmarketing, infrequent
• omeprazole
• oxaliplatin: 1% - 20%
• paclitaxel: very common
• pantoprazole
• paroxetine: rare, infrequent
• pazopanib: 0% - 32%
• phenylbutyric acid: 6%
• ponatinib: 1% - 37%
• posaconazole: 1.66% - 1.67%
• pravastatin
• pregabalin: infrequent
• quetiapine: infrequent
• raltegravir
• rapamycin
• retinoic acid: postmarketing
• rifabutin: 1%
• rifapentine
• riluzole: infrequent, uncommon
• rivastigmine: infrequent
• ropinirole: infrequent, 3%
• ropivacaine: 2.1%
• saquinavir
• sertraline
• sibutramine
• simvastatin
• sunitinib
• tacrolimus
• telithromycin
• temozolomide: uncommon
• temsirolimus
• thalidomide: postmarketing
• tigecycline: 2.6% - 3.5%
• tobramycin
• topiramate: infrequent
• tramadol
• trametinib: 2% - 67%
• trimetrexate: 0% - 4.59%
• valdecoxib
• venlafaxine: infrequent
• vismodegib
• voriconazole: 1.57% - 5%
• zalcitabine
• ziprasidone: infrequent
• zolmitriptan: rare
• zolpidem: rare